These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38542297)
1. Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease. Kumar R; Chowdhury S; Ledeen R Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542297 [TBL] [Abstract][Full Text] [Related]
2. Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouse. Itokazu Y; Fuchigami T; Morgan JC; Yu RK Mol Ther; 2021 Oct; 29(10):3059-3071. PubMed ID: 34111562 [TBL] [Abstract][Full Text] [Related]
3. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease. Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177 [TBL] [Abstract][Full Text] [Related]
4. GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro. Fazzari M; Di Biase E; Zaccagnini L; Henriques A; Callizot N; Ciampa MG; Mauri L; Carsana EV; Loberto N; Aureli M; Mari L; Civera M; Vasile F; Sonnino S; Bartels T; Chiricozzi E; Lunghi G Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159350. PubMed ID: 37330108 [TBL] [Abstract][Full Text] [Related]
5. GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease. Schneider JS; Singh G; Williams CK; Singh V Mol Cell Neurosci; 2022 May; 120():103729. PubMed ID: 35447351 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain. Svarcbahs R; Julku UH; Myöhänen TT J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963 [TBL] [Abstract][Full Text] [Related]
8. Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model Mice. Fuchigami T; Itokazu Y; Morgan JC; Yu RK Mol Neurobiol; 2023 Jun; 60(6):3329-3344. PubMed ID: 36849668 [TBL] [Abstract][Full Text] [Related]
9. Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein. Wang W; Nguyen LT; Burlak C; Chegini F; Guo F; Chataway T; Ju S; Fisher OS; Miller DW; Datta D; Wu F; Wu CX; Landeru A; Wells JA; Cookson MR; Boxer MB; Thomas CJ; Gai WP; Ringe D; Petsko GA; Hoang QQ Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9587-92. PubMed ID: 27482083 [TBL] [Abstract][Full Text] [Related]
10. The relationship between depletion of brain GM1 ganglioside and Parkinson's disease. Sonnino S FEBS Open Bio; 2023 Sep; 13(9):1548-1557. PubMed ID: 36638010 [TBL] [Abstract][Full Text] [Related]
11. Interaction of Alpha Synuclein and Microtubule Organization Is Linked to Impaired Neuritic Integrity in Parkinson's Patient-Derived Neuronal Cells. Seebauer L; Schneider Y; Drobny A; Plötz S; Koudelka T; Tholey A; Prots I; Winner B; Zunke F; Winkler J; Xiang W Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163733 [TBL] [Abstract][Full Text] [Related]
12. Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson's Disease. Butkovich LM; Houser MC; Chalermpalanupap T; Porter-Stransky KA; Iannitelli AF; Boles JS; Lloyd GM; Coomes AS; Eidson LN; De Sousa Rodrigues ME; Oliver DL; Kelly SD; Chang J; Bengoa-Vergniory N; Wade-Martins R; Giasson BI; Joers V; Weinshenker D; Tansey MG J Neurosci; 2020 Sep; 40(39):7559-7576. PubMed ID: 32868457 [TBL] [Abstract][Full Text] [Related]
13. GM1 specifically interacts with alpha-synuclein and inhibits fibrillation. Martinez Z; Zhu M; Han S; Fink AL Biochemistry; 2007 Feb; 46(7):1868-77. PubMed ID: 17253773 [TBL] [Abstract][Full Text] [Related]
15. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease. Zondler L; Miller-Fleming L; Repici M; Gonçalves S; Tenreiro S; Rosado-Ramos R; Betzer C; Straatman KR; Jensen PH; Giorgini F; Outeiro TF Cell Death Dis; 2014 Jul; 5(7):e1350. PubMed ID: 25058424 [TBL] [Abstract][Full Text] [Related]
16. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy. Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198 [TBL] [Abstract][Full Text] [Related]
17. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft. Park JY; Kim KS; Lee SB; Ryu JS; Chung KC; Choo YK; Jou I; Kim J; Park SM J Neurochem; 2009 Jul; 110(1):400-11. PubMed ID: 19457104 [TBL] [Abstract][Full Text] [Related]
18. Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation. Pieger K; Schmitt V; Gauer C; Gießl N; Prots I; Winner B; Winkler J; Brandstätter JH; Xiang W Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009004 [TBL] [Abstract][Full Text] [Related]
19. GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease. Schneider JS; Aras R; Williams CK; Koprich JB; Brotchie JM; Singh V Sci Rep; 2019 Jun; 9(1):8362. PubMed ID: 31182727 [TBL] [Abstract][Full Text] [Related]
20. Alpha-synuclein-induced stress sensitivity renders the Parkinson's disease brain susceptible to neurodegeneration. Nakos Bimpos M; Karali K; Antoniou C; Palermos D; Fouka M; Delis A; Tzieras I; Chrousos GP; Koutmani Y; Stefanis L; Polissidis A Acta Neuropathol Commun; 2024 Jun; 12(1):100. PubMed ID: 38886854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]